BEUDAMED
    1,791 results · 35ms · Sources: EU EUDAMED, US FDA

    Immunocytochemistry Assay, P16/Ki-67

    FDA Pre-Market Approval
    FDA Class 3 ·CINtec PLUS Cytology

    Immunocytochemistry Assay, P16/Ki-67

    FDA Pre-Market Approval
    FDA Class 3 ·CINtec PLUS Cytology

    Stent, Central Venous

    FDA Pre-Market Approval
    FDA Class 3 ·Venous Wallstent™ and Wallstent™ Venous Endoprosthesis with Unistep Plus™ Delivery System

    Stent, Central Venous

    FDA Pre-Market Approval
    FDA Class 3 ·WALLSTENT VENOUS ENDOPROSTHESIS WITH UNISTEP PLUS DELIVERY SYSTEM

    Immunohistochemistry Test, Dna Mismatch Repair (Mmr) Protein Assay

    FDA Pre-Market Approval
    FDA Class 3 ·VENTANA MMR RxDx Panel Solid Tumors with dMMR status)

    Stent, Central Venous

    FDA Pre-Market Approval
    FDA Class 3 ·Wallstent™ Venous Endoprosthesis with Unistep Plus™ Delivery System

    Stent, Central Venous

    FDA Pre-Market Approval
    FDA Class 3 ·Wallstent (Venous) Endoprosthesis With Unistep Plus Delivery System

    Stent, Central Venous

    FDA Pre-Market Approval
    FDA Class 3 ·Wallstent (Venous) Endoprosthesis with unistep plus delivery system

    Stent, Central Venous

    FDA Pre-Market Approval
    FDA Class 3 ·WALLSTENT (VENOUS) ENDOPROSTHESIS

    Stent, Central Venous

    FDA Pre-Market Approval
    FDA Class 3 ·WALLSTENT (VENOUS) ENDOPROSTHESIS

    Stent, Central Venous

    FDA Pre-Market Approval
    FDA Class 3 ·Wallstent Venous Endoprosthesis with UNISTEP Plus

    Immunohistochemistry Test, Dna Mismatch Repair (Mmr) Protein Assay

    FDA Pre-Market Approval
    FDA Class 3 ·VENTANA MMR RxDx Panel, VENTANA ANTI-MLH1 (M1), VENTANA ANTI-MSH6 (SP93), VENTANA ANTI-MSH2 (G219-1129), VENTANA ANTI-PM

    Stent, Central Venous

    FDA Pre-Market Approval
    FDA Class 3 ·WALLSTENT RP ENDOPROSTHESIS AND WALLSTENT ENDOPROSTHESIS (VENOUS)

    Stent, Central Venous

    FDA Pre-Market Approval
    FDA Class 3 ·WALLSTENT (VENOUS) ENDOPROSTHESIS

    Immunohistochemistry Test, Dna Mismatch Repair (Mmr) Protein Assay

    FDA Pre-Market Approval
    FDA Class 3 ·VENTANA MMR RxDx Panel

    Stent, Central Venous

    FDA Pre-Market Approval
    FDA Class 3 ·WALLSTENT VENOUS ENDOPROSTHESIS

    Immunohistochemistry Test, Dna Mismatch Repair (Mmr) Protein Assay

    FDA Pre-Market Approval
    FDA Class 3 ·VENTANA MMR RxDx Panel

    Immunohistochemistry Test, Dna Mismatch Repair (Mmr) Protein Assay

    FDA Pre-Market Approval
    FDA Class 3 ·VENTANA MMR RxDx Panel

    Stent, Central Venous

    FDA Pre-Market Approval
    FDA Class 3 ·WALLSTENT VENOUS ENDOPROSTHESIS

    Stent, Central Venous

    FDA Pre-Market Approval
    FDA Class 3 ·Wallstent Venous Endoprosthesis with Unistep Plus Delivery System